SCHEMBL12246766

SCHEMBL12246766

O=C(CCc1ccc(O)cc1)OCCc1ccc(O)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 2/20 0.67
TDP1 Q9NUW8 2/20 0.63
MET P08581 4/20 0.54
TYR P14679 1/20 0.54
CA12 O43570 1/20 0.54
CA1 P00915 1/20 0.54
CA4 P22748 1/20 0.54
CA6 P23280 1/20 0.54
CA5A P35218 1/20 0.54
CA7 P43166 1/20 0.54
CA9 Q16790 1/20 0.54
CA14 Q9ULX7 1/20 0.54
CA5B Q9Y2D0 1/20 0.54
ALOX5 P09917 1/20 0.54
ESR1 P03372 3/20 0.53
ESR2 Q92731 2/20 0.53
CYP4F2 P78329 1/20 0.51
CYP4A11 Q02928 1/20 0.51
MAPT P10636 2/20 0.51
NPC1 O15118 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17107198 0.96 TDP1 (0.68) APPTDP1METTYRCA12
SCHEMBL19047031 0.94 APP (0.59) APPTDP1METTYRCA12
SCHEMBL15153058 0.92 APP (0.62) APPTDP1METTYRCA12
SCHEMBL12246779 0.92 APP (0.58) APPTDP1METTYRCA12
SCHEMBL15164333 0.89 APP (0.54) APPTDP1METTYRCA12
SCHEMBL12009646 0.89 TDP1 (0.59) APPTDP1METTYRCA12
SCHEMBL12246764 0.89 APP (0.88) APPTDP1TYRCA12CA1
SCHEMBL22693977 0.89 MAPT (0.69) APPTDP1METALOX5MAPT
SCHEMBL24196713 0.87 APP (0.53) APPTDP1METTYRCA12
SCHEMBL16659807 0.87 TDP1 (0.58) APPTDP1METALOX5ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4727926-A1 VITRIMERS WITH WIDE PROCESSING WINDOW LUXEMBOURG INSTITUTE OF SCIENCE AND TECHNOLOGY (LIST) (LU) 2026-04-22 EP disclosed
US-20260071023-A1 POLYESTER THERMOSETS FROM ESTER-CONTAINING EPOXY AND AMINE COMPONENTS THE UNIVERSITY OF SOUTHERN MISSISSIPPI (US) 2026-03-12 US disclosed
WO-2024256725-A1 VITRIMERS WITH WIDE PROCESSING WINDOW LUXEMBOURG INSTITUTE OF SCIENCE AND TECHNOLOGY (LIST) (LU) 2024-12-19 WO disclosed
US-20240301134-A1 POLYMERIC BIOMATERIALS DERIVED FROM PHENOLIC MONOMERS AND THEIR MEDICAL USES RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2024-09-12 US disclosed
US-12030983-B2 Polymeric biomaterials derived from phenolic monomers and their medical uses RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2024-07-09 US disclosed
US-12030983-B2 Polymeric biomaterials derived from phenolic monomers and their medical uses RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2024-07-09 US disclosed
US-12030983-B2 Polymeric biomaterials derived from phenolic monomers and their medical uses RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2024-07-09 US disclosed
EP-3394024-B1 POLYMERIC BIOMATERIALS DERIVED FROM PHENOLIC MONOMERS AND THEIR MEDICAL USES UNIV RUTGERS (US) 2023-08-02 EP disclosed
EP-3394024-B1 POLYMERIC BIOMATERIALS DERIVED FROM PHENOLIC MONOMERS AND THEIR MEDICAL USES UNIV RUTGERS (US) 2023-08-02 EP disclosed
US-20230167238-A1 POLYMETRIC BIOMATERIALS DERIVED FROM PHENOLIC MONOMERS AND THEIR MEDICAL USES RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2023-06-01 US disclosed
US-20130272983-A1 Para-Coumaric Acid or Para-Hydroxycinnamic Acid Derivatives and their Use in Cosmetic or Dermatological Compositions Universite Joseph Fourier-Grenoble 1. (FR) 2013-10-17 US disclosed
US-20130272983-A1 Para-Coumaric Acid or Para-Hydroxycinnamic Acid Derivatives and their Use in Cosmetic or Dermatological Compositions Universite Joseph Fourier-Grenoble 1. (FR) 2013-10-17 US disclosed
US-20130203713-A1 POLYMERIC BIOMATERIALS DERIVED FROM PHENOLIC MONOMERS AND THEIR MEDICAL USES RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2013-08-08 US disclosed
US-20130203713-A1 POLYMERIC BIOMATERIALS DERIVED FROM PHENOLIC MONOMERS AND THEIR MEDICAL USES RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2013-08-08 US disclosed
US-8481593-B2 Para-coumaric acid or para-hydroxycinnamic acid derivatives and their use in cosmetic or dermatological compositions BASF BEAUTY CARE SOLUTIONS S.A.S. (FR) 2013-07-09 US disclosed
US-8481593-B2 Para-coumaric acid or para-hydroxycinnamic acid derivatives and their use in cosmetic or dermatological compositions BASF BEAUTY CARE SOLUTIONS S.A.S. (FR) 2013-07-09 US disclosed
US-20110237551-A1 Para-Coumaric Acid or Para-Hydroxycinnamic Acid Derivatives and Their Use in Cosmetic or Dermatological Compositions BASF BEAUTY CARE SOLUTIONS FRANCE S.A.S. (FR) 2011-09-29 US disclosed
US-20110237551-A1 Para-Coumaric Acid or Para-Hydroxycinnamic Acid Derivatives and Their Use in Cosmetic or Dermatological Compositions BASF BEAUTY CARE SOLUTIONS FRANCE S.A.S. (FR) 2011-09-29 US disclosed
US-20070183996-A1 Para-coumaric acid or para-hydroxycinnamic acid derivatives and their use in cosmetic or dermatological compositions BASF BEAUTY CARE SOLUTIONS FRANCE S.A.S. (FR) 2007-08-09 US disclosed
US-20070183996-A1 Para-coumaric acid or para-hydroxycinnamic acid derivatives and their use in cosmetic or dermatological compositions BASF BEAUTY CARE SOLUTIONS FRANCE S.A.S. (FR) 2007-08-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130203713-A1 POLYMERIC BIOMATERIALS DERIVED FROM PHENOLIC MONOMERS AND THEIR MEDICAL USES TH, TYR, MYB APP 807/4885TDP1 178/4885MET 2205/4885
US-20110237551-A1 Para-Coumaric Acid or Para-Hydroxycinnamic Acid Derivatives and Their Use in Cosmetic or Dermatological Compositions TYR, CUTA, HPD APP 2129/4885TDP1 2072/4885MET 3530/4885
US-12030983-B2 Polymeric biomaterials derived from phenolic monomers and their medical uses TH, TYR, MYB APP 835/4885TDP1 170/4885MET 2184/4885
US-20070183996-A1 Para-coumaric acid or para-hydroxycinnamic acid derivatives and their use in cosmetic or dermatological compositions TYR, CUTA, HPD APP 2180/4885TDP1 2103/4885MET 3566/4885
US-20240301134-A1 POLYMERIC BIOMATERIALS DERIVED FROM PHENOLIC MONOMERS AND THEIR MEDICAL USES TH, TYR, MYB APP 807/4885TDP1 178/4885MET 2205/4885
US-20260071023-A1 POLYESTER THERMOSETS FROM ESTER-CONTAINING EPOXY AND AMINE COMPONENTS COL2A1, EBP, ZYX APP 983/4885TDP1 472/4885MET 2000/4885
US-20130272983-A1 Para-Coumaric Acid or Para-Hydroxycinnamic Acid Derivatives and their Use in Cosmetic or Dermatological Compositions TYR, CUTA, HPD APP 2180/4885TDP1 2103/4885MET 3566/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.